Effect of Somatostatin in Necrolytic Migratory Erythema of Glucagonoma
- 12 January 1985
- journal article
- case report
- Published by Wiley in Acta Medica Scandinavica
- Vol. 218 (2) , 245-249
- https://doi.org/10.1111/j.0954-6820.1985.tb08855.x
Abstract
A 63-year-old woman with necrolytic migratory erythema associated with a glucagonoma in the pancreas is described. The diagnosis was suggested on the basis of a characteristic lesion in skin biopsy. Infusion of somatostatin (25 micrograms/h) for 48 hours was followed by a rapid and almost complete healing of the skin eruptions. Serum glucagon was depressed during infusion. No significant changes in plasma glucose were detected. As the patient experienced a cramp-like sensation after cessation of somatostatin infusion, a tail-off period in the infusion program is advocated. The pathogenesis of necrolytic erythema in glucagonoma is discussed.Keywords
This publication has 10 references indexed in Scilit:
- Effects of Somatostatin on Bronchial Constriction in a Patient with Carcinoid SyndromeNew England Journal of Medicine, 1980
- Pancreatic glucagonoma with and without syndromeVirchows Archiv, 1980
- Effect of somatostatin infusion on jejunal water and electrolyte transport in a patient with secretory diarrhea due to malignant carcinoid syndromeGastroenterology, 1980
- RAPID IMPROVEMENT OF SKIN LESIONS IN GLUCAGONOMAS WITH INTRAVENOUS SOMATOSTATIN INFUSIONThe Lancet, 1980
- New specific long-acting somatostatin analogues in the treatment of pancreatic endocrine tumoursGastroenterology, 1978
- Determination of Gastrin in SerumScandinavian Journal of Gastroenterology, 1973
- Radioimmunological determination of pancreatic and gut glucagon in plasmaDiabetologia, 1971
- CUTANEOUS MANIFESTATIONS OF INTERNAL MALIGNANT TUMORSArchives of Dermatology, 1942